PCR 기술 시장 : 제품, 기술, 용도, 최종 용도별 - 세계 예측

Global PCR Technologies Market will showcase over 8.1% CAGR from 2024 to 2032, catapulted by the heightened adoption of forensic and environmental testing. In forensic science, PCR is instrumental in analyzing genetic material for criminal investigations, enhancing the accuracy of evidence collection and identification. In environmental testing, PCR is used to detect pollutants and contaminants in soil, water, and air, offering precise and rapid results. This broadened application highlights the versatility of PCR technologies in tackling complex challenges, driving continued investment and development. Quoting an instance, In February 2023, Thermo Fisher Scientific rolled out the Applied Biosystems TaqPath PCR kits in India. These kits validated for clinical use, were produced with Mylab Discovery Solutions, and support the detection of infectious diseases such as MTB MDR and HBV.

The PCR technologies market is grouped based on product, technique, application, end-use, and region.

The consumables segment will evince a remarkable CAGR through 2032, due to the emphasis on precision and reliability in molecular diagnostics. As healthcare systems focus on personalized medicine and early disease detection, the need for high-quality consumables is surging. With search for accurate results and consistent performance in PCR testing, alongside the expanding range of applications for PCR technologies will fuel the demand for consumables, ensuring segment growth.

The conventional PCR segment will grab a noteworthy market share by 2032, driven by the techniques established reliability and cost-effectiveness. This technique remains a preferred method for routine genetic analysis and research due to its simplicity and accuracy. As more laboratories and research institutions seek dependable and affordable solutions for DNA analysis, the demand for conventional PCR thrives. The widespread adoption of PCR technologies in educational and clinical settings supports its enduring popularity.

The gene expression analysis segment will exhibit a strong CAGR during the forecast period, owing to the elevating need for detailed insights into gene function and regulation. Researchers and clinicians are focusing on understanding gene expression patterns to advance personalized medicine and therapeutic development. As gene expression studies are integral to scientific and medical advancements, the requirement for reliable PCR-based techniques for analyzing gene activity catapults the demand.

North America PCR technologies market size will expand at a notable pace during 2024-2032, because of a robust healthcare infrastructure and investments in medical research. The regions advanced healthcare systems prioritize precision diagnostics and personalized medicine. There is increased funding for research initiatives and a strong emphasis on innovative medical technologies stimulate. The presence of leading biotechnology firms and research institutions accelerates the adoption of advanced PCR technologies in the region, bolstering the market growth.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing demand for molecular diagnostics and POCT testing
    • 3.2.1.2 Advancement in PCR technologies
    • 3.2.1.3 Increasing prevalence of infectious diseases and genetic disorders
    • 3.2.1.4 Increasing research and development activities
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High cost of PCR devices
    • 3.2.2.2 Dearth of trained experts
• 3.3 Growth potential analysis
• 3.4 Future market trends
• 3.5 Technological landscape
• 3.6 GAP analysis
• 3.7 Regulatory landscape
• 3.8 Porter's analysis
• 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Competitive positioning matrix
• 4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Kits & reagents
• 5.3 Consumables
  • 5.3.1 PCR tubes
  • 5.3.2 PCR microplates
  • 5.3.3 Cap/lids
  • 5.3.4 Other consumables
• 5.4 Instruments
• 5.5 Software & services

Chapter 6 Market Estimates and Forecast, By Technique, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Conventional PCR
• 6.3 Real-time PCR
• 6.4 Digital PCR
• 6.5 Reverse transcription PCR
• 6.6 Hot-start PCR
• 6.7 Multiplex PCR
• 6.8 Other techniques

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Gene expression analysis
• 7.3 Genetic sequencing
• 7.4 Genotyping
• 7.5 Nucleic acid detection
• 7.6 Nucleic acid synthesis
• 7.7 Standard validation/ verification
• 7.8 Diagnostic application
• 7.9 Other applications

Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Hospitals & diagnostic centers
• 8.3 Research & academics institutes
• 8.4 Pharma & biotech companies
• 8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
  • 9.3.7 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
  • 9.5.4 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE
  • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 Abbott Laboratories
• 10.2 Agilent Technologies, Inc.
• 10.3 bioMerieux S.A.
• 10.4 Bio-Rad Laboratories, Inc
• 10.5 Danaher Corporation
• 10.6 Eppendorf SE
• 10.7 F. Hoffmann-LA Roche Ltd.
• 10.8 Illumina, Inc.
• 10.9 Merck KGaA
• 10.10 New England Biolabs
• 10.11 Promega Corporation
• 10.12 QIAGEN N.V.
• 10.13 Standard Biotools Inc.
• 10.14 Takara Holdings Inc.
• 10.15 Thermo Fisher Scientific Inc.